 |
 |
 |
 |
 |
 |
 |
 |
 |
Clinical Management of HIV
-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral TherapyCME/CE CENTRAL
Free credit for U.S. physicians, nurses and pharmacists!An Evaluation of Routine HIV Testing and Its Impact on HAART Initiation
HIV/HAART-RELATED
COMPLICATIONS
COMPLICATIONS
- H1N1 Influenza (Swine Flu)
- Hepatitis C Coinfection
- Cardiovascular Complications
- Metabolic Complications
- OI Treatment Guidelines
CONFERENCE COVERAGE
 |
CROI 2010 Gerald Pierone, M.D., explains why this year's CROI may mark the beginning of the end for the HIV drug development process. |
MONITORING ASSAYS
BREAKING RESEARCH & CLINICAL NEWS
- New Method May Help Identify Drugs That Can Reactivate Latent HIV (From Journal of Clinical Investigation)
- Antiretrovirals in Development: An Update on Recent Research (From The Body PRO's ICAAC 2009 coverage)
- Efavirenz Dose Reduction May Be Safe for Patients Experiencing Adverse Effects (From JAIDS)
- Four-Drug, Three-Class Combination Achieves High Viral Suppression Rate in Treatment-Experienced Patients (From Clinical Infectious Diseases)
- New Data on Vicriviroc Affirm Safety, Efficacy at 96 Weeks (From The Body PRO's ICAAC 2009 coverage)
- HIV-Infected People May Face Significantly Greater Colon Cancer Risk, Study Finds (From Gut)
Antiretrovirals
Drug-Drug Interaction Warnings
RECENT APPROVALS
- Etravirine (TMC125, Intelence) 1/18/08
- Raltegravir (MK-0518, Isentress) 10/12/07
- Maraviroc (Selzentry) 8/7/07
- Efavirenz/Tenofovir/
Emtricitabine (Atripla) 7/12/06 - Darunavir (TMC114, Prezista) 6/23/06
FEATURED INTERVIEWS
 |
Todd Brown, M.D., Ph.D., and Ben Young, M.D., Ph.D., focus on the etiology, diagnosis and treatment of bone disease in HIV-infected people. |
 |
An Interview With Matthew Goetz, M.D. |
 |
An Interview With Joel Gallant, M.D., M.P.H. |
|
An Interview With Joel Gallant, M.D., M.P.H. |
 |
A Discussion With David Wohl, M.D. |
